Trials / Completed
CompletedNCT04860050
Turmeric for Memory Impairment and Cognition
A Double Blind, Parallel, Placebo-controlled, Randomised Clinical Trial to Evaluate the Efficacy of Turmipure Gold® to Improve Cognitive Performance in Healthy Aging.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 568 (actual)
- Sponsor
- Givaudan France Naturals · Industry
- Sex
- All
- Age
- 60 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to test the capacity of acute and chronic supplementations of Turmipure GOLD® to improve cognitive performance in healthy aging
Detailed description
The aim of this clinical study is to determine whether oral administration of Turmipure GOLD® can contribute to the short- and long-term improvement of cognitive functions, including memory and attention, in subjects with age-associated memory impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Turmipure Gold® | TPG: Turmipure GOLD® - 1 capsule per day - as prescribed |
| DIETARY_SUPPLEMENT | Placebo | Placebo: colored acacia gum - 1 capsule per day - as prescribed |
Timeline
- Start date
- 2021-04-19
- Primary completion
- 2023-08-10
- Completion
- 2023-08-10
- First posted
- 2021-04-26
- Last updated
- 2024-01-18
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT04860050. Inclusion in this directory is not an endorsement.